At the Throwback Brewery, Kamala Harris pivoted to the future, separating herself a little more from Bidenomics as she tries to run as a change candidate from an incumbent administration who is driving Donald Trump to distraction. The vice president on Wednesday stopped in New Hampshire — home to 4…

There’s been a growing interest lately in phased retirement, as indicated by the results of several surveys. For example, more than half (52%) of pre-retirees wish to continue working in some way after they retire, according to The Retirement Outlook of the American Middle Class, a survey whose results were…

Our goal here at Credible Operations, Inc., NMLS Number 1681276, referred to as “Credible” below, is to give you the tools and confidence you need to improve your finances. Although we do promote products from our partner lenders who compensate us for our services, all opinions are our own. The…

Seven GOP-led states have filed a lawsuit challenging the Biden administration’s most recent student debt forgiveness plan, accusing the U.S. Department of Education (DOE) of taking steps to cancel loans beginning as early as this week. The lawsuit comes nearly a week after the Supreme Court denied the Biden administration’s…

Billionaire investor Ken Griffin’s suite of hedge funds at Citadel eked out small gains in what proved a volatile month in August as markets grappled with an emerging growth scare. Citadel’s multistrategy Wellington fund gained about 1% in August, bringing its year-to-date return to 9.9%, according to a person familiar…

Atlanta Federal Reserve President Raphael Bostic signaled Wednesday that he is ready to start lowering interest rates even though inflation is still running above the central bank’s target.Previously one of the more hawkish policymakers, or in favor of tighter policy to fight inflation, Bostic noted that his focus is shifting…

Nvidia, the AI chipmaking titan that was briefly the world’s most valuable company, has suddenly found itself in an unfamiliar position: a major rut. Nvidia (NVDA) had the worst day in the history of the stock market Tuesday, as measured by loss in total market value. Its 9.5% share price…

Prime Medicine, Inc. (NASDAQ:PRME) is a gene-editing biotech. Its main platform is Prime Editing, a next-generation technology that can deliver accurate, adaptable, and safer one-time treatments for genetic diseases. This approach can potentially correct specific mutations without the disruptive double-stranded breaks produced by other systems. The company has a diverse…

Stay informed with free updatesSimply sign up to the Equities myFT Digest — delivered directly to your inbox.European and Asian stock markets slid on Wednesday as investors worried about a potential US economic slowdown and sold highly valued technology stocks following a sharp drop in chipmaker Nvidia’s share price.The benchmark…

While Donald Trump faces a fresh indictment over efforts to overturn the 2020 election, some of his biggest allies are hoping the revised charging document helps them evade professional consequences and criminal prosecution for their roles nearly four years ago. Special counsel Jack Smith rewrote Trump’s federal indictment after the…